Erälinna J[au] - Search Results

Year	Number of Results
1994	2
1996	2
1998	1
2001	2
2002	4
2003	1
2004	1
2005	2
2006	4
2007	2
2008	3
2010	2
2011	2
2013	1
2024	0

1

Cytokines in experimental herpes simplex virus infection.

Hukkanen V, Broberg E, Salmi A, Erälinna JP. Hukkanen V, et al. Among authors: eralinna jp. Int Rev Immunol. 2002 Jul-Oct;21(4-5):355-71. doi: 10.1080/08830180213276. Int Rev Immunol. 2002. PMID: 12486819 Review.

2

[Vaccinations and neurological disease].

Erälinna JP. Erälinna JP. Duodecim. 2010;126(7):803-9. Duodecim. 2010. PMID: 20597329 Review. Finnish.

3

[Are vitamins dangerous?].

Laaksonen S, Erälinna JP, Falck B. Laaksonen S, et al. Among authors: eralinna jp. Duodecim. 2001;117(2):180-2. Duodecim. 2001. PMID: 12092370 Finnish. No abstract available.

4

Multippeliskleroosin hoito kannattaa aloittaa varhain.

Ruutiainen J, Elovaara I, Pirttilä T, Erälinna JP, Färkkilä M, Koivisto K, Reunanen M. Ruutiainen J, et al. Among authors: eralinna jp. Duodecim. 2006;122(18):2181-2. Duodecim. 2006. PMID: 17115639 Finnish. No abstract available.

5

Ambient air quality and occurrence of multiple sclerosis relapse.

Oikonen M, Laaksonen M, Laippala P, Oksaranta O, Lilius EM, Lindgren S, Rantio-Lehtimäki A, Anttinen A, Koski K, Erälinna JP. Oikonen M, et al. Among authors: eralinna jp. Neuroepidemiology. 2003 Jan-Feb;22(1):95-9. doi: 10.1159/000067108. Neuroepidemiology. 2003. PMID: 12566960

6

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.

Kappos L, Traboulsee A, Constantinescu C, Erälinna JP, Forrestal F, Jongen P, Pollard J, Sandberg-Wollheim M, Sindic C, Stubinski B, Uitdehaag B, Li D. Kappos L, et al. Among authors: eralinna jp. Neurology. 2006 Sep 26;67(6):944-53. doi: 10.1212/01.wnl.0000237994.95410.ce. Neurology. 2006. PMID: 17000959 Clinical Trial.

7

Physical state of the neuroantigen in adjuvant emulsions determines encephalitogenic status in the BALB/c mouse.

Määttä JA, Erälinna JP, Röyttä M, Salmi AA, Hinkkanen AE. Määttä JA, et al. Among authors: eralinna jp. J Immunol Methods. 1996 Mar 28;190(1):133-41. doi: 10.1016/0022-1759(95)00273-1. J Immunol Methods. 1996. PMID: 8601706

8

Downregulation of VLA-4 on T cells as a marker of long term treatment response to interferon beta-1a in MS.

Soilu-Hänninen M, Laaksonen M, Hänninen A, Erälinna JP, Panelius M. Soilu-Hänninen M, et al. Among authors: eralinna jp. J Neuroimmunol. 2005 Oct;167(1-2):175-82. doi: 10.1016/j.jneuroim.2005.06.022. J Neuroimmunol. 2005. PMID: 16087245 Clinical Trial.

9

Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.

Peltoniemi J, Broberg EK, Nygårdas M, Erälinna JP, Waris M, Hukkanen V. Peltoniemi J, et al. Among authors: eralinna jp. Int Immunopharmacol. 2006 May;6(5):817-29. doi: 10.1016/j.intimp.2005.12.003. Epub 2006 Jan 4. Int Immunopharmacol. 2006. PMID: 16546713

10

Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.

Oikonen M, Laaksonen M, Aalto V, Ilonen J, Salonen R, Erälinna JP, Panelius M, Salmi A. Oikonen M, et al. Among authors: eralinna jp. Mult Scler. 2011 Jun;17(6):672-80. doi: 10.1177/1352458510394397. Epub 2011 Jan 6. Mult Scler. 2011. PMID: 21212088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year